6-Aminopyridine-3-carboxamide structure, CAS 329-89-5

6-Aminopyridine-3-carboxamide

CAS Number329-89-5

Synonyms6-Aminonikotinsaeureamid; 2-Amino-5-carbamoylpyridine; Nicotinamide,6-amino; 6-Aminopyridine-3-carboxamide; FDA 0121; 6-aminonicotinamid; 2-Aminopyridine-5-carboxamide; 6-aminonicotinic amide; 6-Aminonicotinic acid amide; Aminonicotinamide; EINECS 206-349-7; 6-Aminonicotinamide; 3-PYRIDINECARBOXAMIDE,6-AMINO; 6-amino-3-pyridinecarboxamide; 6-amino-nicotinamide; MFCD00006327

Molecular FormulaC6H7N3O

Molecular Weight137.14

Purity99%

Density1.3±0.1 g/cm3

Boiling Point381.6±27.0 °C at 760 mmHg

Melting Point245-248 °C (lit.)

Flash Point

Appearancepowder

EINECS206-349-7

MSDSChineseEnglish

SymbolTransport

Signal WordWarning

Cat. No.: 2A-9021322 Purity: 99%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 329-89-5 ] Purity: 99% SDS Specification MoL

Chemical & Physical Properties
CAS Number329-89-5
Catalog No.2A-9021322
Chinese Name6-氨基烟酰胺
Synonyms6-Aminonikotinsaeureamid; 2-Amino-5-carbamoylpyridine; Nicotinamide,6-amino; 6-Aminopyridine-3-carboxamide; FDA 0121; 6-aminonicotinamid; 2-Aminopyridine-5-carboxamide; 6-aminonicotinic amide; 6-Aminonicotinic acid amide; Aminonicotinamide; EINECS 206-349-7; 6-Aminonicotinamide; 3-PYRIDINECARBOXAMIDE,6-AMINO; 6-amino-3-pyridinecarboxamide; 6-amino-nicotinamide; MFCD00006327
Molecular FormulaC6H7N3O
Molecular Weight137.14
Purity99
Density1.3±0.1 g/cm3
Boiling Point381.6±27.0 °C at 760 mmHg
Melting Point245-248 °C (lit.)
Appearancepowder
Storage ConditionThis product should be sealed and stored away from
PackagingII
Application6-Aminonicotinamide, a potent nicotinamide antimetabolite, is a competitive inhibitor (Ki=0.46 μM) of the NADP+-dependent enzyme glucose-6-phosphate dehydrogenase (G6PD). 6-Aminonicotinamide interfere
EINECS206-349-7
HTC2933399090
PubChem ID24891142
MDL NumberMFCD00006327
SMILESNC(=O)c1ccc(N)nc1
InChI1S/C6H7N3O/c7-5-2-1-4(3-9-5)6(8)10/h1-3H,(H2,7,9)(H2,8,10)
InChI KeyZLWYEPMDOUQDBW-UHFFFAOYSA-N
Beilstein/REAXYS116042
NACRES CodeNA.22
UNSPSC12352100
Hazard SymbolsTransport
MSDSmsds/21322_1_329_89_5.pdf
Bioactivity6-Aminonicotinamide, a potent antimetabolite of nicotinamide, is competitive NADP+-dependent enzyme glucose-6-phosphate dehydrogenase (G6PD) inhibitor (Ki=0.46 μM). 6-Aminonicotinamide interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, such as Cisplatin, in killing cancer cells[1][2][3][4]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Others >> Others In Vitro 6-Aminonicotinamide (100 nM; 7 days) causes a significant decrease in the human AR+, hormone-sensitive prostate cancer cell lines LNCaP and LAPC4, as well as the CRPC-derivative C4-2 and 22Rv1 cell models. 6-Aminonicotinamide (100 nM ± 10 nM R1881 as indicated for 3 days) increases both basal- and R1881-mediated ROS levels, suggesting 6-Aminonicotinamide is blocking the cells' antioxidant defense. 6-Aminonicotinamide also increases ROS levels in C4-2 cells[3]. In Vivo 6-Aminonicotinamide (20 mg/kg; i.p.; thress times; days 1, 10 or 11, and 21) alone induces a small but significant tumor growth delay (4.3±0.8 days). Treatment with 6-Aminonicotinamide followed by radiation induces a tumor growth delay of 57.0±3.8 days in CD8F1 breast tumor model[4]. References [1]. Cheng J, et al. TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism. Nat Commun. 2020;11(1):1880. Published 2020 Apr 20. [2]. Almugadam SH, et al. Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: Beyond the pentose phosphate pathway. Chem Biol Interact. 2018;294:167-177. [3]. Tsouko E, et al. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis. 2014;3(5):e103. Published 2014 May 26. [4]. Koutcher JA, et al. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Magn Reson Med. 1996;36(6):887-892. Chemical & Physical Properties Density 1.3±0.1 g/cm3 Boiling Point 381.6±27.0 °C at 760 mmHg Melting Point 245-248 °C(lit.) Molecular Formula C6H7N3O Molecular Weight 137.139 Flash Point 184.6±23.7 °C Exact Mass 137.058914 PSA 82.00000 LogP 0.41 Vapour Pressure 0.0±0.9 mmHg at 25°C Index of Refraction 1.644 InChIKey ZLWYEPMDOUQDBW-UHFFFAOYSA-N SMILES NC(=O)c1ccc(N)nc1
Use of6-Aminonicotinamide, a potent antimetabolite of nicotinamide, is competitive NADP+-dependent enzyme glucose-6-phosphate dehydrogenase (G6PD) inhibitor (Ki=0.46 μM). 6-Aminonicotinamide interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, such as Cisplatin, in killing cancer cells[1][2][3][4]. Properties Articles31 Name 6-aminonicotinamide Synonym More Synonyms 6-Aminonicotinamide Biological Activity Description 6-Aminonicotinamide, a potent antimetabolite of nicotinamide, is competitive NADP+-dependent enzyme glucose-6-phosphate dehydrogenase (G6PD) inhibitor (Ki=0.46 μM). 6-Aminonicotinamide interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, such as Cisplatin, in killing cancer cells[1][2][3][4]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Others >> Others References [1]. Cheng J, et al. TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism. Nat Commun. 2020;11(1):1880. Published 2020 Apr 20. [2]. Almugadam SH, et al. Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: Beyond the pentose phosphate pathway. Chem Biol Interact. 2018;294:167-177. [3]. Tsouko E, et al. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis. 2014;3(5):e103. Published 2014 May 26. [4]. Koutcher JA, et al. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Magn Reson Med. 1996;36(6):887-892. Chemical & Physical Properties Molecular Formula C6H7N3O Exact Mass 137.058914 PSA 82.00000 Index of Refraction 1.644 InChIKey ZLWYEPMDOUQDBW-UHFFFAOYSA-N
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoShipping Name: UN
MSDS Transport InfoModule 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available
Related Products in Heterocyclic Building Blocks
Thiazolyl Blue298-93-12A-9021144
2-(Trifluoromethyl)benzimidazole312-73-22A-9021215
8-Trifluoromethylquinoline317-57-72A-9021237
2-Amino-6-(trifluoromethylsufanyl)benzothiazole326-45-42A-9021281
5-Nitro-2-trifluoromethylbenzimidazole327-19-52A-9021286
2,5-Dihydro-2,5-dimethoxyfuran332-77-42A-9021340
6-(Trifluoromethyl)indoline-2,3-dione343-69-12A-9021372
3-(2-Aminoethyl)indole hydrochloride343-94-22A-9021375
4-Fluoroindoline-2,3-dione346-34-92A-9021398
6-Fluoro-1H-indazole348-25-42A-9021404
Browse all Heterocyclic Building Blocks products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA